A Study of DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian Tumors

NCT04707248 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

179

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Cell Carcinoma
Ovarian Tumor

Interventions

DRUG: DS-6000a
DRUG: DS-6000a

Sponsor

Daiichi Sankyo

Collaborators

[object Object]